Press release |

While we welcome the recent withdrawal of harmful provisions from the IP chapter of RCEP, namely patent term extensions and data exclusivity, Japan’s strong push for elevated IP enforcement measures continues to be a matter of grave concern.

Read more

What good is a breakthrough medicine if the people who need it can't afford it?